Due to an aging population, visual impairment from neovascular age-related macular degeneration (nAMD) is increasing in the United States. Despite unprecedented improvements in vision preservation ...

In patients with a diagnosis of early- or intermediate-stage nonneovascular age-related macular degeneration (AMD), exposure to levodopa was associated with a significantly reduced risk for conversion ...

Please provide your email address to receive an email when new articles are posted on . Neovascular glaucoma (NVG) is historically known as rubeotic glaucoma, from the rubeosis iridis that refers to ...

Preoperative diagnosis of neovascular glaucoma was associated with an increased risk for developing hypotony after transscleral diode cyclophotocoagulation, or TCP, according to a study. Furthermore, ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...

Neovascular AMD, while less common than its dry counterpart, causes nearly all cases of sudden, irreversible central vision loss due to abnormal blood vessel growth that damages the macula.

In a large proportion of cases (up to 39%), the cause cannot be fully identified; as a result they are described as idiopathic. 1 There are two types of PCNM, and correct pre-interventional ...

Neovascular glaucoma (NVG) is a type of glaucoma caused by neovascularization of the angle that eventually leads to peripheral anterior synechiae and consequent angle closure. Numerous ocular ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.

Neovascular glaucoma (NVG) occurs when blood vessels grow over the iris and anterior chamber of the eye. This prevents fluid from draining, raising pressure in the eye and potentially affecting vision ...